Metabolic and toxicological considerations regarding CGRP mAbs and CGRP antagonists to treat migraine in Covid-19 patients: a narrative review
Description
INTRODUCTION: Migraine pharmacological therapies targeting calcitonin gene-related peptide (CGRP), including monoclonal antibodies and gepants, have shown clinical effect and optimal tolerability. Interactions between treatments of Covid-19 and CGRP
